Inventor

MUNOZ BENITO

US66 patents

⚠️ This page may combine multiple inventors who share the name “MUNOZ BENITO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MUNOZ BENITO

PROTEOSTASIS THERAPEUTICS INC

Compounds, compositions, and methods of increasing CFTR activity

Derivatives of 5-phenyl- or 5-heteroarylathiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis

Compounds, compositions, and methods for increasing CFTR activity

Compounds, compositions, and methods for increasing CFTR activity

Compounds, compositions, and methods for increasing CFTR activity

Compounds, compositions, and methods for increasing CFTR activity

Compounds, compositions, and methods for increasing CFTR activity

Proteasome activity enhancing compounds

Compounds, compositions, and methods for modulating CFTR

Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis

Compounds, compositions, and methods for modulating CFTR

Proteasome activity enhancing compounds

Compounds, compositions, and methods for modulating CFTR

Compounds, compositions, and methods for increasing CFTR activity

Compounds, compositions, and methods of increasing CFTR activity

Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis

Compounds, compositions, and methods for increasing CFTR activity

Proteasome activity enhancing compounds

Compounds, compositions, and methods for increasing CFTR activity

Compounds, compositions, and methods for modulating CFTR

BROAD INST INC

Kinase inhibitors and methods of use thereof

Kinase inhibitors and methods of use thereof

Compounds and methods for the treatment of malaria

Kinase inhibitors and methods of use thereof

Compounds and methods for the treatment of malaria

Compounds and methods for the treatment of malaria

Compounds and compositions for the treatment of cancer

Kinase inhibitors and methods of use thereof

Compounds and methods for the treatment of isocitrate dehydrogenase related diseases

MERCK & CO INC

Solid phase synthesis of heterocycles

Sulfonamide compounds and uses thereof

Metabotropic glutamate receptor-5 modulators

Geminally di-substituted NSAID derivatives as Aβ42 lowering agents

Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5

Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators

Cysteinyl protease inhibitors

Prodrugs of (2R)-2-propyloctanoic acid for the treatment of stroke

SIBIA NEUROSCIENCES INC

Methods of treating neurodegenerative disorders using protease inhibitors

Methods of treating neurodegenerative disorders using protease inhibitors

Methods of treating neurodegenerative disorders using protease inhibitors

Peptide and peptide analog protease inhibitors

Peptide and peptide analog protease inhibitors

Peptide, peptide analog and amino acid analog protease inhibitors

Peptide and peptide analog protease inhibitors

Peptide, peptide analog and amino acid analog protease inhibitors

WHITEHEAD INST BIOMEDICAL RES

Thiohydantoin derivatives and uses thereof

Indazole derivatives and uses thereof

KINETA INC

Proteasome activity enhancing compounds

Proteasome activity enhancing compounds

SCRIPPS RESEARCH INST

Tight-binding inhibitors of leukotriene A4 hydrolase